 |
Mariangellys Rodriguez
|
E-mail: rodri242@umn.edu
Year entered: 2007
Thesis Advisor: David
Potter
Degree received:
B.S., Chemistry, University of Puerto Rico, Puerto Rico, 2007
Honors and Awards:
- Graduate School DOVE Fellowship, 2007-2008
- American Association for Cancer Research (AARC) Minority
Scholar in Cancer Research Award, April 2009
- Top 3% poster/abstract recognition AARC, April 2009
- Records Chair of the Association of Multicultural Scientists,
May 2009-
- Department of Medicine’s Research Day Poster Competition
Award 2009
Thesis research:
My research project studies the role of lipid metabolism
in breast cancer progression. Breast cancer is the second
leading cause of cancer deaths in the US. The risk of breast
cancer is increased by hormonal factors and gain of weight
during adulthood. It is known that hormones such as estrogen
and insulin-like growth factors (IGF) increase the risk of
breast cancer mainly by promoting the growth of breast epithelium.
However, the signaling pathway by which hormone factors affect
breast cancer has not been elucidated. Moreover, the biological
mechanism by which weight gain affects breast cancer is not
understood. The long-term goal of my project is to understand
how both hormonal signaling and bioactive food components
cooperate to influence the development of breast cancer. The
proposed studies will investigate the role of hormone signaling
(specifically, IGF1) and the metabolism of a dietary lipid
(eicosapentaenoic acid, an omega-3 fatty acid commonly found
in fish oil) in the proliferation and survival of breast cancer
cells. Preliminary studies indicated that insulin-like growth
factor 1 (IGF1) induces cytochrome P450 1A1 (CYP1A1) expression
in breast cancer. CYP1A1 metabolizes omega-3 fatty acid EPA
into 17(18)-epoxyeicosatetraenoic acid, which is a potential
promoter of tumor progression. The hypothesis to be tested
is that cytochrome P450 1A1, induced by activated IGF1 receptor,
metabolizes eicosapentaenoic acid into 17(18)-epoxyeicosatetraenoic
acid, thereby promoting breast cancer proliferation and survival.
|